Terazosin for vesicosphincter dyssynergia in spinal cord-injured male patients

Molecular Urology

Volumn 4, Issue 4, 2000, Pages 415-419

  Bennett, J K ^a   Foote, J ^a   El Leithy, T R ^a   Saleem, M D ^a   Green, B ^a   Archer, C L ^a   Gray, M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; TERAZOSIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; BLADDER PRESSURE; BLADDER SPHINCTER; CONTROLLED STUDY; DETRUSOR DYSSYNERGIA; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; SPINAL CORD INJURY;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; ATAXIA; HUMANS; MALE; MIDDLE AGED; PRAZOSIN; PROSPECTIVE STUDIES; SPINAL CORD INJURIES; TIME FACTORS; URETHRA; UROLOGIC DISEASES;

EID: 0033635454     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Placement of a wire mesh prosthesis in the external urinary sphincter of men with spinal cord injuries
2. Long-term urologic management of the patient with spinal cord injury
3. Urethral sphincter dyssynergia in spinal cord injury patients
4. Control and coordination of bladder and urethral function in the brainstem
5. Sphincterotomy failure in neurogenic bladder disease
6. The value of urodynamics and bladder management in predicting upper urinary tract complications in male spinal cord injury patients
7. The use of urodynamic studies to assess the effect of pharmacological agents with particular references to alpha-adrenergic blockade
8. Urodynamics and management of the neuropathic bladder in spinal cord injury patients
9. Clean intermittent self-catheterization in the treatment of urinary tract disease
10. The safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia
11. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck
12. The use of alpha-adrenergic blockers in benign prostatic obstruction
13. 1 adrenergic receptor in human benign prostatic hyperplasia
14. Medical treatment of benign prostatic hyperplasia: 5 Alpha-reductase inhibitors and alpha-adrenergic antagonists
15. Prostatic alpha adrenoceptors
16. Clinical experience with symptomatic management of BPH with terazosin
17. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia
18. Sympathetic dyssynergia in the region of the external sphincter: A possible source of lower urinary tract obstruction
19. Urodynamic studies in evaluating detrusor sphincter dyssynergia and their effects on the treatment
20. Bladder neck opening test in spinal cord injury patients using a new i.v. alpha-blocking agent, alfuzosin
21. Contraction of urinary bladder by central norepinephrine originating in the locus coeruleus
22. The effect of terazosin on bladder function in the spinal cord injured patient
23. Anatomic innervation of the muscles in the bladder wall and proximal urethra in male rats
24. Characteristics of the urethral pressure profile in flaccid male paraplegics
25. A new theory of the innervation of bladder musculature 4: Innervation of the vesicourethral junction and external urethral sphincter
26. Detrusor bladder neck dyssynergia revisited
27. Efficacy and safety of terazosin to improve voiding in spinal cord injury patients
28. Clinical effect of alpha-1 antagonism on external and internal urinary sphincter function